[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@boobuddycrypto](/creator/twitter/boobuddycrypto) "This is why analysts are calling it biotechs DeepSeek moment: Just like DeepSeek stunned the world with its AI models Akeso is proving that China can lead the next wave of medical innovation"  [@boobuddycrypto](/creator/x/boobuddycrypto) on [X](/post/tweet/1944666414289506450) 2025-07-14 07:52:57 UTC XXX followers, XX engagements "Meet Ivonescimab made by biotech firm Akeso. Its the worlds first PD-1/VEGF bispecific antibody combining two cancer-fighting weapons in one: PD-1: supercharges immune system VEGF: blocks tumor blood supply One drug. Two attacks"  [@boobuddycrypto](/creator/x/boobuddycrypto) on [X](/post/tweet/1944666400376897762) 2025-07-14 07:52:54 UTC XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@boobuddycrypto
"This is why analysts are calling it biotechs DeepSeek moment: Just like DeepSeek stunned the world with its AI models Akeso is proving that China can lead the next wave of medical innovation" @boobuddycrypto on X 2025-07-14 07:52:57 UTC XXX followers, XX engagements
"Meet Ivonescimab made by biotech firm Akeso. Its the worlds first PD-1/VEGF bispecific antibody combining two cancer-fighting weapons in one: PD-1: supercharges immune system VEGF: blocks tumor blood supply One drug. Two attacks" @boobuddycrypto on X 2025-07-14 07:52:54 UTC XXX followers, XX engagements
/creator/twitter::478320322/posts